gimli
ALIVUS stock analysis context
ALIVUS LIFE SCIENCES Stock Context for AI Screening
ALIVUS LIFE SCIENCES LTD is a small-cap stock in Healthcare. This page summarizes key screening signals for ALIVUS LIFE SCIENCES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about ALIVUSPrice
₹1,039.00
1M return
-1.69%
3M return
+14.06%
Market cap
₹12,752.63 cr
PE
22.13
ROE
+22.38%
RSI
45.08
Turnover
₹8.74 cr
Why it can matter in screens
- Momentum: ALIVUS is above 50DMA, above 200DMA; RSI is 45.08.
- Returns: 1M -1.69%, 3M +14.06%, 6M +14.95%.
- Liquidity: latest turnover is ₹8.74 cr.
- Valuation: PE 22.13, PB 3.83, ROE +22.38%, ROCE +29.63%.
- Growth: 3Y sales CAGR +3.88%, 3Y profit CAGR +5.06%.
Try these prompts
- Analyze ALIVUS LIFE SCIENCES with valuation, momentum and industry peers
- Compare ALIVUS with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ALIVUS with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.